Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ulcer recurrence: cytokines and inflammatory response-dependent process

T Arakawa1, T Watanabe, T Fukuda

  • 1Third Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan.

Digestive Diseases and Sciences
|September 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of prostaglandin and cimetidine in protection of isolated gastric glands against indomethacin injury.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2005
Same author

Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B.

Biochemical and biophysical research communications·2005
Same author

Molecular mechanisms of ulcer healing.

Drug news & perspectives·2003
Same author

Expression of serum response factor in normal rat gastric mucosa.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2002
Same author

Effect of Helicobacter pylori culture supernatant on acute reflux esophagitis in a rat model.

Hepato-gastroenterology·2002
Same author

Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways.

Journal of physiology, Paris·2001

Peptic ulcer recurrence is linked to impaired prostaglandin E2 generation and inflammatory responses at the ulcer scar site. Enhancing ulcer healing quality with gastroprotective drugs can reduce recurrence rates.

Area of Science:

  • Gastroenterology
  • Pathophysiology
  • Pharmacology

Background:

  • Helicobacter pylori (H. pylori) and nonsteroidal anti-inflammatory drugs (NSAIDs) are key factors in peptic ulcer disease recurrence.
  • However, ulcers can recur even in patients negative for H. pylori and not using NSAIDs, suggesting other mechanisms are involved.

Purpose of the Study:

  • To review recent data on the mechanisms underlying peptic ulcer recurrence.
  • To explore the role of prostaglandin generation, inflammatory responses, and cytokine production in ulcer healing quality and recurrence.

Main Methods:

  • Review of recent scientific literature on peptic ulcer recurrence mechanisms.
  • Analysis of experimental data on prostaglandin depletion, indomethacin treatment, and inflammatory cell infiltration in gastric ulcers.

Related Experiment Videos

  • Examination of clinical findings relating ulcer healing quality to inflammatory cell infiltration and recurrence.

    • Main Results:

    • Impaired prostaglandin E2 generation at ulcer scar sites and prostaglandin depletion during healing can lead to poor healing quality and increased recurrence.
    • Persistent polymorphonuclear cell infiltration in gastric ulcer scars is associated with recurrence.
    • Gastroprotective drugs, including prostaglandin analogs and inducers, improve healing quality and reduce recurrence.
    • Inflammatory cytokines like interleukin-1beta and tumor necrosis factor-alpha, stimulated by factors such as NSAIDs and H. pylori, contribute to ulcer recurrence.

    Conclusions:

    • The quality of ulcer healing, influenced by prostaglandin levels and inflammatory responses at the scar site, is critical in preventing peptic ulcer recurrence.
    • Targeting inflammatory responses and supporting prostaglandin synthesis with gastroprotective agents may offer therapeutic strategies to reduce ulcer recurrence.